Creative Planning Puma Biotechnology, Inc. Transaction History

Creative Planning

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 01, 2019	SELL	$20.07 - $46.7 $156,626 - $364,446	-7,804 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$41.2 - $59.85 $110,210 - $160,098	2,675 Added 52.15%	7,804 $358,000
Q2 2018 Jul 20, 2018	BUY	$48.3 - $68.25 $57,380 - $81,081	1,188 Added 30.14%	5,129 $303,000
Q1 2018 Apr 18, 2018	BUY	$59.7 - $99.25 $55,043 - $91,508	922 Added 30.54%	3,941 $268,000
Q4 2017 Jan 17, 2018	BUY	$93.85 - $132.45 $50,772 - $71,655	541 Added 21.83%	3,019 $298,000
Q3 2017 Oct 17, 2017	BUY	$72.0 - $119.75 $178,416 - $296,740	2,478	2,478 $297,000

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $134M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.